Ke Xiao
0000-0002-6599-7118
Publication & Citation Trends
Most Cited Works
Publications
192 total
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial PDF
Cited by 551
OpenAlex
A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity PDF
Cited by 100
OpenAlex
Circulating cardiovascular <scp>microRNAs</scp> in critically ill <scp>COVID</scp> ‐19 patients PDF
Cited by 154
OpenAlex
Ocular manifestations and clinical characteristics of 535 cases of COVID‐19 in Wuhan, China: a cross‐sectional study PDF
Cited by 337
OpenAlex
Preclinical development of a miR-132 inhibitor for heart failure treatment PDF
Cited by 207
OpenAlex
<p>Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway</p> PDF
Cited by 118
OpenAlex
Targeting muscle-enriched long non-coding RNA <i>H19</i> reverses pathological cardiac hypertrophy PDF
Cited by 117
OpenAlex
Research Topics
Cancer-related molecular mechanisms research
(22)
Circular RNAs in diseases
(20)
MicroRNA in disease regulation
(16)
Retinal Diseases and Treatments
(13)
RNA modifications and cancer
(10)
Frequent Co-Authors
Affiliations
Fujian University of Traditional Chinese Medicine
University of London
Chongqing Normal University
Kaneka (United States)
Central South University